Contact us for a free case consultation 866-281-8659

Living Safer Magazine

Check out the latest issue of D’Amore Law Group’s Living Safer magazine!


Archive for the ‘Gadolinium Contrast’ Category

Risk of Fatal Kidney Condition Results in New Warnings for Gadolinium-Based Contrasts Used in MRI and MRA Procedures
Saturday, November 20th, 2010

Gadolinium-based contrast agents (GBCAs) are intravenous drugs used in diagnostic imaging procedures to enhance the quality of magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA). Earlier this year, the FDA announced it was requiring that GBCA's carry new warnings about the risk of nephrogenic systemic fibrosis (NSF) when these drugs are administered to certain […]